330 related articles for article (PubMed ID: 29477358)
1. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
[TBL] [Abstract][Full Text] [Related]
2. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.
Apellániz B; Rujas E; Carravilla P; Requejo-Isidro J; Huarte N; Domene C; Nieva JL
J Virol; 2014 Nov; 88(22):13367-77. PubMed ID: 25210180
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface.
Rujas E; Caaveiro JM; Partida-Hanon A; Gulzar N; Morante K; Apellániz B; García-Porras M; Bruix M; Tsumoto K; Scott JK; Jiménez MÁ; Nieva JL
Sci Rep; 2016 Dec; 6():38177. PubMed ID: 27905530
[TBL] [Abstract][Full Text] [Related]
5. Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.
Wang Y; Kaur P; Sun ZJ; Elbahnasawy MA; Hayati Z; Qiao ZS; Bui NN; Chile C; Nasr ML; Wagner G; Wang JH; Song L; Reinherz EL; Kim M
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22556-22566. PubMed ID: 31624123
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol Constrains the Antigenic Configuration of the Membrane-Proximal Neutralizing HIV-1 Epitope.
Torralba J; de la Arada I; Carravilla P; Insausti S; Rujas E; Largo E; Eggeling C; Arrondo JLR; Apellániz B; Nieva JL
ACS Infect Dis; 2020 Aug; 6(8):2155-2168. PubMed ID: 32584020
[TBL] [Abstract][Full Text] [Related]
7. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
Irimia A; Serra AM; Sarkar A; Jacak R; Kalyuzhniy O; Sok D; Saye-Francisco KL; Schiffner T; Tingle R; Kubitz M; Adachi Y; Stanfield RL; Deller MC; Burton DR; Schief WR; Wilson IA
PLoS Pathog; 2017 Feb; 13(2):e1006212. PubMed ID: 28225819
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
Virology; 2017 May; 505():113-126. PubMed ID: 28237764
[TBL] [Abstract][Full Text] [Related]
9. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing Antibodies Targeting HIV-1 gp41.
Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
[TBL] [Abstract][Full Text] [Related]
11. Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
Sutar J; Padwal V; Sonawani A; Nagar V; Patil P; Kulkarni B; Hingankar N; Deshpande S; Idicula-Thomas S; Jagtap D; Bhattacharya J; Bandivdekar A; Patel V
Virus Res; 2019 Nov; 273():197763. PubMed ID: 31553924
[TBL] [Abstract][Full Text] [Related]
12. Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.
Kim AS; Leaman DP; Zwick MB
PLoS Pathog; 2014 Jul; 10(7):e1004271. PubMed ID: 25058619
[TBL] [Abstract][Full Text] [Related]
13. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
[TBL] [Abstract][Full Text] [Related]
14. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
[TBL] [Abstract][Full Text] [Related]
15. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
16. An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene.
Sun Z; Zhu Y; Wang Q; Ye L; Dai Y; Su S; Yu F; Ying T; Yang C; Jiang S; Lu L
Emerg Microbes Infect; 2016 Jun; 5(6):e65. PubMed ID: 27329850
[TBL] [Abstract][Full Text] [Related]
17. The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region.
Apellániz B; Rujas E; Serrano S; Morante K; Tsumoto K; Caaveiro JM; Jiménez MÁ; Nieva JL
J Biol Chem; 2015 May; 290(21):12999-3015. PubMed ID: 25787074
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Pinto D; Fenwick C; Caillat C; Silacci C; Guseva S; Dehez F; Chipot C; Barbieri S; Minola A; Jarrossay D; Tomaras GD; Shen X; Riva A; Tarkowski M; Schwartz O; Bruel T; Dufloo J; Seaman MS; Montefiori DC; Lanzavecchia A; Corti D; Pantaleo G; Weissenhorn W
Cell Host Microbe; 2019 Nov; 26(5):623-637.e8. PubMed ID: 31653484
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope.
Torralba J; de la Arada I; Partida-Hanon A; Rujas E; Arribas M; Insausti S; Valotteau C; Valle J; Andreu D; Caaveiro JMM; Jiménez MA; Apellániz B; Redondo-Morata L; Nieva JL
Commun Biol; 2022 Nov; 5(1):1265. PubMed ID: 36400835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
